• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX, SA VITEK MS PRIME

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX, SA VITEK MS PRIME Back to Search Results
Model Number 423281
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Intended use: vitek® ms is a mass spectrometry system using matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) for the identification of microorganisms cultured from human specimens.The vitek® ms system is a qualitative in-vitro diagnostic device indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial, yeast and mold infections.Issue description: a customer in portugal notified biomérieux of a misidentification of escherichia coli as moellerella wisconsensis in association with vitek ms prime ref.(b)(4), lot es00113.Alternate method testing was performed via vitek 2 with results of escherichia coli.Repeat testing was performed on vitek ms prime with results of escherichia coli.At the time of assessment, there is no indication or report from the customer that this event led to any adverse event related to any patient's state of health or any delay in treatment.
 
Manufacturer Narrative
An investigation was initiated in response to one customer complaint relating to a misidentification of escherichia coli as moellerella wisconsensis.---investigation--- knowledgebase review: the expected identification is unknown because no reference method was used to confirm the expected identification.Fine tuning: according to the vilink alert tool criteria, fine tuning was needed during the tests made on 16 nov 2022 spot preparation quality: the customer¿s spot preparation quality was not optimal.The calibrator and sample ¿all peaks¿ values were heterogeneous.Customer data review: analysis of mzml sample files shows that the number of "all peaks" are heterogeneous during the issue (31 and 63).Moreover, the misidentification was obtained with a low identification score (-0.26) and a low level of peaks (31) which is at the acceptable limit for giving an ¿identification¿ result or a ¿no identification¿ result (respectively 30 peaks and -0.4).This could be explained by a non-optimal spot preparation of the sample strain (culture, spot, different operator¿) or a non-optimal fine tuning.The spot providing the misidentification as moellerella wisconsen was very thin.If a spot is too thin, not enough organism have been deposited on the spot.Consequently, the ionization will not be efficient.The amount of ¿all peaks¿ detected during acquisition will be not sufficient for allowing good identification.In addition, analysis of average spectra show that for the spectra f3 giving the misidentification, the number of rejected profile count was 87 versus a number of accepted profile count of 59.In comparison, for the spectra j3 giving the expected identification, the number of rejected profile count was 26 versus a number of accepted profile count of 120.The information highlights that the spectra f3 was not of good quality.Identify and verify root causes: -non optimal spot preparation - fine tuning drifted ---conclusion--- review of customer data indicated non optimal spot preparation and that fine tuning was needed during the impacted tests.Global customer service (gcs) performed a complaint trend analysis and did not identify this issue as a trend.
 
Event Description
Intended use: vitek® ms is a mass spectrometry system using matrix-assisted laser desorption/ionization time of flight mass spectrometry (maldi-tof ms) for the identification of microorganisms cultured from human specimens.The vitek® ms system is a qualitative in-vitro diagnostic device indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial, yeast and mold infections.Issue description: a customer in portugal notified biomérieux of a misidentification of escherichia coli as moellerella wisconsensis in association with vitek ms prime (ref.(b)(4), lot es00113).Alternate method testing was performed via vitek 2 with results of escherichia coli.Repeat testing was performed on vitek ms prime with results of escherichia coli.At the time of assessment, there is no indication or report from the customer that this event led to any adverse event related to any patient's state of health or any delay in treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK MS PRIME
Type of Device
VITEK MS PRIME
Manufacturer (Section D)
BIOMÉRIEUX, SA
3, route de port michaud
la balme les grottes 38390
FR  38390
Manufacturer (Section G)
BIOMÉRIEUX, SA
3, route de port michaud
la balme les grottes 38390
FR   38390
Manufacturer Contact
benjamen jost
595 anglum road
hazelwood, MO 63042
MDR Report Key15917156
MDR Text Key306108502
Report Number9615754-2022-00143
Device Sequence Number1
Product Code QBN
UDI-Device Identifier03573026611422
UDI-Public03573026611422
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
K212461
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number423281
Device Catalogue Number423281
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/25/2022
Initial Date FDA Received12/05/2022
Supplement Dates Manufacturer Received12/12/2022
Supplement Dates FDA Received01/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-